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Abstract 
Purpose: To determine the prevalence of smoking among diabetes patients attending Diabetes 
Outpatient Clinic at Penang General Hospital, Penang, Malaysia. 
Methods: A cross-sectional study was undertaken to assess the smoking status of all the patients that 
registered at the above clinic. The data were extracted from the diabetes patients’ medical records. 
Between June 1st 2010 and June 30th 2011, all medical records of type 1 and 2 diabetes patients were 
reviewed to assess the prevalence of smoking. 
Results: Of 2547 diabetes patients, 447 patients were excluded from the analysis as their smoking 
status was unknown, leaving 2100 diabetes patients whose smoking status was determined. The 
prevalence of smoking in diabetes patients was estimated at 8 %. Smokers had shorter duration of 
diabetes mellitus than non-smokers (6.70 ± 5.16 vs. 8.42 ± 6.66; respectively, p = 0.001). Smoking was 
significantly associated with male gender and younger age (p < 0.0001). Chinese diabetes patients 
were the most prevalent race among smokers, compared with Malay and Indian (50.3, 30.5 and 19.2 %, 
respectively); however, the differences were statistically not significant , p = 0.219). 
Conclusion: The prevalence of smoking among diabetes patients of the Malaysian clinic at Penang 
studied was low. On the other hand, smoking status was inadequately documented and no information 
was available on the history of tobacco use in diabetes smokers. 
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Tobacco smoking is a reprehensible habit that 
has spread all over the world as an epidemic. It 
is one of the main risk factors for a number of 
chronic diseases, including cancer, lung 
diseases, and cardiovascular diseases [1].  
In diabetes mellitus (DM), several prospective 
studies found that cigarette smoking acts as 
independent contributors to the occurrence of 
cardiovascular disease (CVD) [2-4]. Smoking 
increases the risk of microvascular complications 
in diabetes patients (i.e., nephropathy, 
retinopathy, and neuropathy) probably due to its 
metabolic effects by worsening diabetes control 
and insulin resistance, beside that it can increase 
inflammation and endothelial dysfunction which 
later contribute to the complications. In addition, 
tobacco use promotes macrovascular diseases 
including coronary heart disease (CHD), stroke, 
and peripheral vascular disease in type 2 
diabetes patients [5].  
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There are more than one billion smokers 
worldwide; of these 125.8 million reside within 
South East Asian countries. In Malaysia, it has 
been estimated that 21.5 % of the adult in the 
country are current smokers. In addition, about 
10-20% of all death reported are attributed to 
smoking [6]. 
 
There is a dearth of information about the 
prevalence of smoking in patients who are at 
greater risk of the complications due to smoking 
habit, including diabetes patients. Few studies 
documented the prevalence of smoking in 
specific groups in Malaysia [7-9]. The current 
study was aimed at determining the prevalence 
of smoking among type 2 diabetes patients in 






Penang General Hospital is the largest tertiary 
public hospital in the state of Penang. It provides 
health care, emergency treatment for all illnesses 
and accidents, and primary and advanced 
medical health care.  
 
A cross-sectional study design was used to 
gather the required data. The medical records 
were reviewed for all diabetes patients who had 
attended the Outpatient Clinic of Penang General 
Hospital between June 1st 2010 and June 30th 
2011. 
 
Additionally, specific demographic and diabetes-
related information were collected. Any medical 
record which did not contain information about 
smoking status was considered missing. The 
study was approved by the ethics committee of 
the Clinical Research Centre, National Institutes 




All analyses were performed using SPSS version 
18.0 (SPSS Inc, Chicago, IL). The significance 
level was set at p < 0.05. Descriptive analyses 
were performed for quantitative (continuous) 
variables by calculating mean ± standard 
deviation (SD), while percentages and 
frequencies were determined for qualitative 
(categorical) variables. To compare the 
proportions between smoker and non-smokers, 
Chi square (χ2) test was applied, while Mann-
Whitney U test was used to evaluate statistical 
differences for quantitative variables that were 




Two thousand five hundred and forty-seven 
(2,547) medical records of type 1 and 2 diabetes 
patients were reviewed to assess the prevalence 
of smoking between June 1st 2010 and June 30th 
2011. Of these, 447 medical records were 
excluded from analysis as their smoking status 
was unknown, giving rise to 2100 records of 
diabetes patients whose smoking status was 
determined. 
 
The ages of patients in the included records 
ranged from 18 to 96 years old (mean = 63.5 
years old). There were just 39.5 % type 1 DM 
patients compared to 60.5 % type 2. The 
Chinese race was the predominant race in the 
whole diabetes patients compare to Malay and 
Indian races (54, 25 and 21 %, respectively). The 
duration of diabetes ranged from less than one 
year to 48 years. Most of the patients were using 
oral anti-diabetes agents as against other types 
of treatment (diet, insulin or oral agent + insulin). 
The study identified that 167 (8 %) of the patients 
whose records were included were smokers 
(Table 1).  
 
In our cohort, Chinese diabetes patients (50.3 %) 
were the most prevalent race among smokers 
compared with Malay (30.5 %) and Indian (19.2 
%); however, the difference were statistically 
insignificant (p = 0.219).  Smoking was 
significantly associated with male gender 
compared to female (88 % vs. 12 %, 
respectively, p < 0.0001). Smoking was 
significantly associated with the younger age of 
diabetes patients compared to age of non-
smoker (61.32 ± 11.380 vs. 63.66 ± 10.783, p = 
0.007). Additionally, there was significant 
association between smoking status and the 
duration of DM following diagnosis. Non-smokers 
had longer duration of DM than smoking patients 





Results from the national Behavioural Risk 
Factor Surveillance System show that the 
prevalence of smoking in young adults with 
diabetes mellitus is similar to the prevalence in 
the general population [10]. Our finding is not 
consistent with the general thought that the 
prevalence of smoking among diabetes patients 
is a mirror of the general population. Other 
studies in the United States found the age-
adjusted prevalence of smoking was 27.3 and  
Table 1: Demographics and other characteristics of smoking vs. non-smoking diabetes patients 
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Smoking status N = 2100 Characteristics 
Smoker 
N = 167 
Non-smokers 
N = 1933 
P value 
























Duration of DMc  6.70 ± 5.16 8.42 ± 6.66  0.001 a 
















a Mann-Whitney U test, b Chi square (χ2) test, c Duration of diabetes following  diagnosis 
 
25.9 % among people with and without diabetes, 
respectively. It did not differ significantly between 
participants in both groups when they were 
stratified by age, sex, race, or education [11]. 
 
Unfortunately, there were 17.6 % diabetes 
patients with unknown smoking status during the 
period of the study which may reflect the 
differences observed in the prevalence of 
smoking with the general population of Malaysia. 
Additionally, among the 2100 subjects whose 
smoking status was determined, there was no 
recorded information about smoking history. 
Another study also reported that smoking status 
is under-recorded among patients with DM; 
suggesting that health care professionals do not 
assess and treat all modifiable risk factors [12]. 
Inadequate documentation of risk factors may 
hamper the achievement of optimal diabetes 
care on an individual level [13]. 
 
For primary prevention of diabetes complications, 
it is recommended to record smoking status as a 
part of routine evaluation including current and 
past smoking history, smoking duration, dose 
(number of cigarettes smoked per day), and even 
the passive exposure to smoke (i.e. at home and 
work). Primary care clinician should strongly 
encourage diabetes smokers and their family to 
quit smoking by providing counselling, 
pharmacotherapies, and formal cessation 
program as appropriate to achieve complete 
cessation [14]. Furthermore, the current update 
of Tobacco Use and Dependence Clinical 
Practice Guideline provides clear evidence of the 
effectiveness of encouraging primary care 
clinicians to expand the vital signs (blood 
pressure, temperature, and pulse rate) by 
document smoking status in primary practice 
[15].  
Male gender was associated to smoking which 
reflect the differences in prevalence of smoking 
in the two sections of the general population in 
Malaysia [6]. However; it was unknown whether 
smoking status was recorded truthfully among 
female due to cultural constraints in Penang 
Island. With regard to prevalence of diabetes 
smokers, there was no significant difference 
between the 3 races. An earlier study conducted 
in Penang island, Malaysia among tuberculosis 
patients found significant differences in 
prevalence according to race - 51.6, 34.8 and 7.2 
% (p = 0.008) for Chinese, Malay and Indian, 
respectively [7]. Furthermore, the duration of DM 
was longer among smokers, probably due to 
probably to the fact that smoking in our cohort is 
significantly associated with younger age. 
 
Limitations of the study 
 
This study was subject to a number of limitations. 
First, there was information bias such as missing, 
unreported or incomplete data in the medical 
records; also it was unknown whether smoking 
status was recorded truthfully which may affect 
the differences observed between male and 
female gender. Secondly, the results of the 
current study may not be generalizable to all 
diabetes patients in Malaysia since the study 





The prevalence of smoking among diabetes 
patients in Malaysia was low and did not reflect 
the prevalence in the general population. 
Smoking status should be evaluated as a routine 
care and advice should be given to those who 
are smokers on the way and steps they should 
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follow to stop smoking; alternatively, they might 
be referred to smoking cessation program which 
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